• Auclair J, Busine MP, Navarro C, Ruano E, Montmain G, Desseigne F, Saurin JC, Lasset C, Bonadona V, Giraud S, Puisieux A, Wang Q. 2006. Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing. Hum Mutat 27:145154.
  • Barnetson RA, Cartwright N, van Vliet A, Haq N, Drew K, Farrington S, Williams N, Warner J, Campbell H, Porteous ME, Dunlop MG. 2008. Classification of ambiguous mutations in DNA mismatch repair genes identified in a population-based study of colorectal cancer. Hum Mutat 29:367374.
  • Chan PA, Duraisamy S, Miller PJ, Newell JA, McBride C, Bond JP, Raevaara T, Ollila S, Nyström M, Grimm AJ, Christodoulou J, Oetting WS, Greenblatt MS. 2007. Interpreting missense variants: comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR). Hum Mutat 28:683693.
  • Cotton RG 2006 Human Variome Project; Appelbe W, Auerbach AD, Becker K, Bodmer W, Boone DJ, Boulyjenkov V, Brahmachari S, Brody L, Brookes A, Brown AF, Byers P, Cantu JM, Cassiman JJ, Claustres M, Concannon P, Cotton RG, den Dunnen JT, Flicek P, Gibbs R, Hall J, Hasler J, Katz M, Kwok PY, Laradi S, Lindblom A, Maglott D, Marsh S, Masimirembwa CM, Minoshima S, de Ramirez AM, Pagon R, Ramesar R, Ravine D, Richards S, Rimoin D, Ring HZ, Scriver CR, Sherry S, Shimizu N, Stein L, Tadmouri GO, Taylor G, Watson M. 2007. Recommendations of the 2006 Human Variome Project meeting. Nat Genet 39:433436.
  • Couch FJ, Rasmussen L, Hofstra R, Monteiro AANM, Greenblatt MS, de Wind N; IARC Unclassified Genetic Variants Working Group. 2008. Assessment of functional effects of unclassified genetic variants. Hum Mutat 29:13141326.
  • Easton DF, Deffenbaugh AM, Pruss D, Frye C, Wenstrup RJ, Allen-Brady K, Tavtigian SV, Monteiro ANA, Iversen ES, Couch FJ, Goldgar DE. 2007. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer–predisposition genes. Am J Hum Genet 81:873883.
  • Fokkema IF, den Dunnen JT, Taschner PE. 2005. LOVD: easy creation of a locus-specific sequence variation database using an “LSDB-in-a-box” approach. Hum Mutat 26:6368.
  • Goldgar DE, Easton DF, Byrnes GB, Spurdle AB, Iversen ES, Greenblatt MS; IARC Unclassified Genetic Variants Working Group. 2008. Integration of various data sources for classifying uncertain variants into a single model. Hum Mutat 29:12651272.
  • Greenblatt MS, Brody LC, Foulkes W, Genuardi M, Hofstra R, Plon S, Sijmons RH, Sinilnikova OM, Spurdle AB; IARC Unclassified Genetic Variants Working Group. 2008. Locus-specific databases and recommendations to strengthen their contribution to the classification of variants in cancer susceptibility genes. Hum Mutat 29:12731281.
  • Hofstra RW, Spurdle AB, Eccles D, Foulkes WD, de Wind N, Hoogerbrugge N, Hogervorst FBL; IARC Unclassified Genetic Variants Working Group. 2008. Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance. Hum Mutat 29:12921303.
  • Korhonen MK, Vuorenmaa E, Nyström M. 2008. The first functional study of MLH3 mutations found in cancer patients. Genes Chromosomes Cancer 47:803809.
  • Lastella P, Surdo NC, Resta N, Guanti G, Stella A. 2006. In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects. BMC Genomics 7:243.
  • Lovelock PK, Spurdle AB, Mok MTS, Farrugia DJ, Lakhani SR, Healey S, Arnold S, Buchanan D; kConFab Investigators, Couch FJ, Henderson BR, Goldgar DE, Tavtigian SV, Chenevix-Trench G, Brown MA. 2007. Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants? Breast Cancer Res 9:R82.
  • Lucci-Cordisco E, Boccuto L, Neri G, Genuardi M. 2006. The use of microsatellite instability, immunohistochemistry and other variables in determining the clinical significance of MLH1 and MSH2 unclassified variants in Lynch syndrome. Cancer Biomark 2:1127.
  • Lynch HT, Boland RC, Gong G, Shaw TG, Lynch PM, Fodde R, Lynch JF, de la Chapelle A. 2006. Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet 14:390402.
  • Ou J, Niessen RC, Lützen A, Sijmons RH, Kleibeuker JH, de Wind N, Rasmussen LJ, Hofstra RMW. 2007. Functional analysis helps to clarify the clinical importance of unclassified variants in DNA mismatch repair genes. Hum Mutat 28:10471054.
  • Peltomäki P, Vasen H. 2004. Mutations associated with HNPCC predisposition—update of ICG-HNPCC/INSiGHT mutation database. Dis Markers 20:269276.
  • Plon SE, Eccles DM, Easton DF, Foulkes W, Genuardi M, Greenblatt MS, Hogervorst FBL, Hoogerbrugge N, Spurdle AB, Tavtigian S; IARC Unclassified Genetic Variants Working Group. 2008. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 29:12821291.
  • Stenson PD, Ball E, Howells K, Phillips A, Mort M, Cooper DN. 2008. Human Gene Mutation Database: towards a comprehensive central mutation database. J Med Genet 45:124126.
  • Tavtigian SV, Greenblatt MS, Lesueur F, Byrnes GB; IARC Unclassified Genetic Variants Working Group. 2008. In silico analysis of missense substitutions using sequence-alignment based methods. Hum Mutat 29:13271336.
  • Woods MO, Williams P, Careen A, Edwards L, Bartlett S, McLaughlin JR, Banfield Younghusband H. 2007. A new variant database for mismatch repair genes associated with Lynch syndrome. Hum Mutat 28:669673.
  • Wu Y, Berends MJW, Sijmons RH, Mensink RGJ, Verlind E, Kooi KA, van der Sluis T, Kempinga C, van der Zee AGJ, Hollema H, Buys CHCM, Kleibeuker JH, Hofstra RMW. 2001. A role for MLH3 in hereditary nonpolyposis colorectal cancer. Nat Genet 29:137138.